Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use
Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy
BMI May Be Prognostic Tool For Types Of Breast Cancer
Postoperative Chemo Doesn’t Improve Survival, Study Finds
Risks Of Long-Term HRT Outweigh Benefits, WHI Finds
Cause Of Allergic Reaction To Cetuximab Found
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









